ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "pathogenesis"

  • Abstract Number: 427 • 2012 ACR/ARHP Annual Meeting

    Epigenetic Features As Predictive Markers of Responsiveness to Epitope-Specific Therapy in Rheumatoid Arthritis

    Roberto Spreafico1, Maura Rossetti1, Theodorus Van Der Broek1, Olivia Morrow1 and Salvatore Albani2, 1Translational Immunology, Sanford-Burnham Medical Research Institute, La Jolla, CA, 2Translational Research Program, Infectious and Inflammatory Diseases, Sanford-Burnham Medical Research Institute, La Jolla, CA

    Background/Purpose: The focus of current research for new therapeutic approaches in Rheumatoid arthritis (RA) is shifting from mere suppression to induction and maintenance of tolerance.…
  • Abstract Number: 2312 • 2012 ACR/ARHP Annual Meeting

    Senescent T Cells Promote Bone Loss in Rheumatoid Arthritis

    Johannes Fessler1, Rusmir Husic2, Elisabeth Lerchbaum3, Verena Schwetz3, Claudia Stiegler3, Barbara Obermayer-Pietsch3, Winfried B. Graninger4 and Christian Dejaco5, 1Rheumatology and Immunology, Medical University Graz, Graz, Austria, 2Rheumatology, Medical University Graz, Graz, Austria, 3Division of Endocrinology and Metabolism, Medical University Graz, Graz, Austria, 4Internal medicine/Rheumatology and Immunology, Medical University Graz, Graz, Austria, 5Rheumatology, Southend University Hospital, Westcliff-on-Sea, United Kingdom

    Background/Purpose:  To study the influence of aged CD28-T cells on systemic osteoporosis in rheumatoid arthritis (RA) patients. Methods:  Prospective, cross-sectional study on 100 patients with…
  • Abstract Number: 406 • 2012 ACR/ARHP Annual Meeting

    βig-h3 Regulates the Inflammatory Arthritis by Mediating Selective Recruitment of Effector/Memory T Cells

    Keum Hee Sa1, Jin Hee Kang1, Mahmudul Md Alam1, Kyung Hwa Lee1, Churl Hyun Im1, Eon Jeong Nam1, In San Kim2 and Young Mo Kang3, 1Internal Medicine (Rheumatology), Kyungpook National University School of Medicine, Daegu, South Korea, 2Biochemistry & Cell Biology, Cell and Matrix Research Institute, Kyungpook National University School of Medicine, Daegu, South Korea, 3Department of Internal Medicine (Rheumatology), Kyungpook National University School of Medicine, Daegu, South Korea

    Background/Purpose: Transforming growth factor-beta inducible gene-h3 (βig-h3) is abundantly expressed in synovial tissues of rheumatoid arthritis (RA) and has a regulatory role in growth, differentiation,…
  • Abstract Number: 2320 • 2012 ACR/ARHP Annual Meeting

    Superantigen Induces IL-17 Production From Extremely Polarized Th1 Clones

    Kentaro Yomogida1, Yuan K. Chou1 and Cong-Qiu Chu2, 1Division of Arthritis and Rheumatic Diseases, Oregon Health & Science University, Portland, OR, 2Rheumatology, Oregon Health & Science Univ and Portland VA Medical Center, Portland, OR

    Background/Purpose: Differentiation of naïve CD4+ T cells is considered to be an irreversible event and, in particular, the plasticity is thought to be completely lost…
  • Abstract Number: 408 • 2012 ACR/ARHP Annual Meeting

    Alpha-Enolase Facilitates Migration of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis

    Kichul Shin1, Ji Ah Park2, Seyeon Bae3, Jae Seung Kang3 and Yeong Wook Song4, 1Rheumatology, College of Medicine, Seoul National University, Seoul, South Korea, 2Division of Rheumatology, Department of Internal Medicine,, Seoul National Hospital, Seoul, South Korea, 3Department of Anatomy and Tumor Immunity Medical Research Center, College of Medicine, Seoul National University, Seoul, South Korea, 4Division of Rheumatology, Department of Internal Medicine, Seoul National University, Seoul, South Korea

    Background/Purpose:Alpha-enolase (ENO1) is a multifunctional glycolytic enzyme ubiquitously expressed in the cytoplasm. Citrullinated ENO1 is reported to be a candidate autoantigen in rheumatoid arthritis (RA),…
  • Abstract Number: 1767 • 2012 ACR/ARHP Annual Meeting

    Circulating Plasmablasts As a Source of Anti-Citrullinated Protein Antibodies in Patients with Rheumatoid Arthritis

    Priscilla Kerkman, Ellen I.H. van der Voort, Leendert A. Trouw, Tom W.J. Huizinga, René E.M. Toes and Hans Ulrich Scherer, Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Anti citrullinated protein antibodies (ACPA) are highly specific for rheumatoid arthritis (RA) and predict disease onset and severity. Accumulating evidence indicates that ACPA could…
  • Abstract Number: 328 • 2012 ACR/ARHP Annual Meeting

    IL-7; An Important Pro-Inflammatory Factor That Affects Myeloid Cell Function in RA and CIA

    Nathan D. Chamberlain1, Seung-jae Kim2, Michael Volin3, Anjali Mehta2, Nadera J. Sweiss4 and Shiva Shahrara1, 1Medicine/Rheumatology, University of Illinois at Chicago, Chicago, IL, 2University of Illinois at Chicago, Chicago, IL, 3Department of Microbiology and Immunology, Chicago College of Osteopathic Medicine Midwestern University, Downers Grove, IL, 4internal medicine section of rheumatology, University of Illinois at Chicago, Chicago, IL

    Background/Purpose: The aim of the study was to examine the role of IL-7 in the pathogenesis of rheumatoid arthritis (RA) as well as in collagen…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology